Pell Bio-Med Technology Co., Ltd.
Research Pell Bio-Med Technology Co., Ltd. (6949.TW) on Bullrun: market cap TWD 51.00B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6949.TW
- ExchangeTW
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 51.00B
- Financial periodQ2 2026
- RevenueTWD 8.95M
- Net income-TWD 88.90M
- Free cash flow-TWD 169.60M
- Gross margin-20.1%
Valuation Snapshot
latest market cap is TWD 51.00B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 51.00B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 TWD.
About Pell Bio-Med Technology Co., Ltd.
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products. It offers autologous adipose-derived stem cell (ADSC) products to treat osteoarthritis and cartilage defects in the knee; cytokine-induced Killer cells to treat various tumors; and dendritic cell-activated cytokine-induced killer to treat solid tumors.
ETFs that hold Pell Bio-Med Technology Co., Ltd.
US-listed ETFs
Pell Bio-Med Technology Co., Ltd. is held by 8 US-listed ETFs, going by the latest portfolios they filed with the SEC, most traded first:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| State Street SPDR Portfolio Emerging Markets ETF (SPEM) | 0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| First Trust Emerging Markets Small Cap AlphaDEX Fund (FEMS) | 1.00% | 0.80% |
| State Street SPDR S&P Emerging Markets Small Cap ETF (EWX) | 0.08% | 0.65% |
| Northern Trust Morningstar Emerging Markets Factor Tilt ETF (TLTE) | 0.01% | 0.57% |
Portfolios as filed with the SEC on Form N-PORT, dated June to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Pell Bio-Med Technology Co., Ltd.'s market cap?
Pell Bio-Med Technology Co., Ltd.'s market capitalization is TWD 51.00B.
What does Pell Bio-Med Technology Co., Ltd. do?
Pell Bio-Med Technology Co., Ltd., a biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products. It offers autologous adipose-derived stem cell (ADSC) products to treat osteoarthritis and cartilage defects in the knee; cytokine-induced Killer cells to treat various tumors; and dendritic cell-activated cytokine-induced killer to treat solid tumors.